sulfinpyrazone has been researched along with Diseases, Metabolic in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naess, K | 1 |
| Nagy, F | 1 |
1 trial available for sulfinpyrazone and Diseases, Metabolic
| Article | Year |
|---|---|
Use of Rabenid for different indications.
Topics: Adult; Aged; Female; Humans; Male; Metabolic Diseases; Middle Aged; Sulfinpyrazone; Uric Acid | 1991 |
1 other study available for sulfinpyrazone and Diseases, Metabolic
| Article | Year |
|---|---|
[Uricosuric agents: Should they be used in asymptomatic hyperuricemia?].
Topics: Allopurinol; Humans; Metabolic Diseases; Probenecid; Sulfinpyrazone; Uric Acid | 1976 |